An interaction between rs299290 and rs6064391 (in intron 2 of CSTF1, Fig. 3B) could reduce breast cancer risk in both BRCA1 and BRCA2 mutation carriers (interaction HRs = 0.87 and 0.73, respectively; Table 1). Here, BRCA2 is linked to breast carcinoma.